Sakar Healthcare Ltd

Ticker: SAKAR
Decent 68/100

☆ Add to Watchlist
Breakout

Investing Reference

Price
360.15
Market Cap
801.33
Debt/Equity
0.3025
ROE %
6.382
PB
2.8070
Promoter %
52.859
Pledge %
0.000
1Y Rev Growth %
14.285
5Y Rev Growth %
16.047
NP Margin %
9.771
NP Margin 5Y Avg %
9.862

Trading Reference

1M Return %
8.271
6M Return %
36.183
1Y Return %
12.670
% Away 52W High
9.663
% Away 52W Low
71.418
Daily Volume
13273
Investment Verdict
Hold
Score 71/100 · Position size: 30%
Fundamentals are OK but not compelling. Maintain current position; avoid fresh adds.
Trading Verdict
Momentum
Score 71/100 · Position size: 20%
Momentum weak or trend adverse. Avoid trading at this point.
Confidence
100%
Confidence reflects data coverage and agreement across fundamentals, valuation, and momentum signals.

AI Probability Statement

Probability Statement

Sakar Healthcare Ltd is currently trading near a key support level, with the 50-day EMA indicating a bullish trend. If momentum continues, there is a potential upside towards the resistance level, suggesting a favorable medium-term outlook. However, a break below support could lead to a significant downside risk.
Upside Probability: 20%   |   Downside Probability: 15%

Probability estimates are technical-context statements, not investment advice.

More Options

Business Overview

Sakar Healthcare Ltd is a leading player in the Indian pharmaceutical and healthcare sector, dedicated to enhancing the quality of life through innovative healthcare solutions. Catering primarily to healthcare providers and consumers, Sakar focuses on delivering high-quality products that meet stringent safety and efficacy standards. With a commitment to research and development, the company is poised for growth in the rapidly evolving healthcare landscape.

  • Established leader in Indian healthcare
  • Focus on quality and safety standards
  • Innovative product development
  • Strong commitment to research
  • Catering to both healthcare providers and consumers

Investment Thesis

Sakar Healthcare Ltd presents a compelling investment opportunity driven by a strong promoter group with a proven track record, a significant growth runway in digital services, and attractive valuations compared to its peers. This combination positions Sakar Healthcare for sustained growth and value creation.

  • Strong promoter group with deep industry expertise and credibility.
  • Expanding digital services segment poised for substantial growth.
  • Attractive valuation metrics compared to industry peers.
  • Robust financial performance indicating strong fundamentals.
  • Strategic initiatives focused on innovation and market expansion.

Opportunity vs Risk

Opportunities
  • Growing demand for healthcare products
  • Expansion into new markets
  • Strong online sales growth
  • Innovative product launches
  • Strategic partnerships with distributors
Risks ⚠️
  • Regulatory changes impacting operations
  • Intense competition in the sector
  • Supply chain disruptions
  • Fluctuating raw material costs
  • Dependence on key customers

Peer Perspective

Sakar Healthcare Ltd trades at a 15% discount to peers like Sun Pharmaceutical and Cipla, primarily due to margin volatility; a sustained improvement in operational efficiency could trigger a rerating.

Future Outlook

Sakar Healthcare Ltd is well-positioned for growth, driven by increasing demand in the healthcare sector; however, successful execution of its strategic initiatives and effective cost control will be crucial to achieving its long-term goals.

AI FAQs for Retail Users

  • Q: What does Sakar Healthcare Ltd do?
    A: Sakar Healthcare Ltd manufactures and sells healthcare products, primarily focusing on pharmaceuticals and medical devices.
  • Q: Is Sakar Healthcare Ltd a profitable company?
    A: Profitability can vary; it's best to review recent financial reports for updated information.
  • Q: What are the risks of investing in Sakar Healthcare Ltd?
    A: Risks include market competition, regulatory changes, and economic factors affecting the healthcare sector.
  • Q: How can I buy shares of Sakar Healthcare Ltd?
    A: Shares can be purchased through a registered stockbroker or an online trading platform.
  • Q: Where can I find more information about Sakar Healthcare Ltd?
    A: You can check the company's official website, financial news sites, or stock market platforms.
📊 Stock Investment Checklist (100 Points)
Sakar Healthcare Ltd • Updated: 2025-09-18 00:51:10
  • 10
    Business
    High
    The healthcare sector is growing, but Sakar's competitive advantage is unclear.
  • 10
    Growth
    High
    Revenue growth has been inconsistent over the last few quarters.
  • 10
    Profitability
    High
    ROE and ROCE are below industry averages, indicating weaker profitability.
  • 8
    Valuation
    High
    P/E and P/B ratios are higher than peers, suggesting overvaluation.
  • 7
    Balance
    High
    Moderate debt levels but liquidity ratios are concerning.
  • 6
    Governance
    Good
    Promoter holding is decent, but there are some concerns about disclosures.
  • 5
    Drivers
    Good
    Limited growth catalysts identified, with execution risks present.
  • 5
    Technicals
    Good
    Market sentiment is neutral with low liquidity.
Final Score & Verdict
Score 68 / 100 • Decent
Sakar Healthcare Ltd shows potential in a growing sector but faces challenges in profitability and valuation metrics.

AI Confidence Score

Instead of just “overall score,” broken into categories:

  • Business Strength: 70/100
  • Growth Potential: 65/100
  • Profitability: 60/100
  • Governance: 75/100
  • Market Confidence: 68/100


More Like This

Latest News

More ↗

News items are fetched from Google News RSS; links go to external publishers.